Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|April 23, 2009
Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomasAline Hébrant, Jacqueline Van Sande, Pierre P Roger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinomaClaire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, et al.
European Journal of Endocrinology|January 17, 2016
Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled studyDavid Taïeb, Claire Bournaud, Marie-Claude Eberle, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Predictive factors of outcome in poorly differentiated thyroid carcinomasChristelle de la Fouchardière, Myriam Decaussin-Petrucci, Julien Berthiller, et al.
European Thyroid Journal|December 27, 2021
Long-Term Outcome of Lobectomy for Thyroid CancerMatthieu Bosset, Maxime Bonjour, Solène Castellnou, et al.
Eclinicalmedicine|April 13, 2026
A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort studyLaurine Mebarki, Elise Andre, Fabien Subtil, et al.
Nuclear Medicine Communications|November 16, 2010
18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumoursFrancesco Giammarile, Claire Billotey, Catherine Lombard-Bohas, et al.
Targeted Oncology|August 20, 2015
Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective StudyChristelle de la Fouchardiere, Nadia Oussaid, Olfa Derbel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2007
Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapyAurore Oudoux, Pierre-Yves Salaun, Claire Bournaud, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
Pageof 8